Pages that link to "Q38746816"

The following pages link to Estrogens in the prevention of osteoporosis in postmenopausal women (Q38746816):

Displaying 48 items.

• Bone metabolism and the perimenopause overview, risk factors, screening, and osteoporosis preventive measures (Q31112720) (← links)
• Effects on bone of oral hormone replacement therapy initiated 2 years after ovariectomy in young adult monkeys (Q32004772) (← links)
• Hormone replacement therapy: I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen deficiency (Q33560609) (← links)
• Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease (Q33560669) (← links)
• In vitro anti-osteoporosis properties of diverse Korean Drynariae rhizoma phenolic extracts (Q33570524) (← links)
• Systematic review of soy isoflavone supplements on osteoporosis in women (Q34252055) (← links)
• Effects of Ulmus davidiana planch on mineralization, bone morphogenetic protein-2, alkaline phosphatase, type I collagen, and collagenase-1 in bone cells (Q34562705) (← links)
• Effects of eleven flavonoids from the osteoprotective fraction of Drynaria fortunei (KUNZE) J. SM. on osteoblastic proliferation using an osteoblast-like cell line (Q34733279) (← links)
• Hormone replacement therapy. Risks, benefits, and costs. (Q36652768) (← links)
• 9 Oestrogen therapy and cardiovascular disease: Do the benefits outweigh the risks? (Q37070505) (← links)
• Nectandrin A Enhances the BMP-Induced Osteoblastic Differentiation and Mineralization by Activation of p38 MAPK-Smad Signaling Pathway (Q37297703) (← links)
• Experimental techniques for screening of antiosteoporotic activity in postmenopausal osteoporosis (Q38555331) (← links)
• Cross-sex testosterone therapy in ovariectomized mice: addition of low-dose estrogen preserves bone architecture. (Q38648384) (← links)
• In vitro estrogenic activity of formononetin by two bioassay systems (Q40203006) (← links)
• Estrogen-like activity and prevention effect of bone loss in calcium deficient ovariectomized rats by the extract of Pleurotus eryngii (Q40268965) (← links)
• Dermatologic diseases and problems of women throughout the life cycle. (Q40472611) (← links)
• Proliferative effects of flavan-3-ols and propelargonidins from rhizomes of Drynaria fortunei on MCF-7 and osteoblastic cells (Q40635725) (← links)
• Aspects of hormone replacement therapy (Q40642655) (← links)
• Trophic factors in aging. Should older people receive hormonal replacement therapy? (Q40696809) (← links)
• A risk-benefit appraisal of transdermal estradiol therapy (Q40800520) (← links)
• Glucocorticoid-induced osteoporosis: pathogenesis, prevention and treatment, with special regard to the rheumatic diseases (Q40836795) (← links)
• Osteoporosis prevention and treatment with sex hormone replacement therapy (Q41144132) (← links)
• The in vitro and in vivo effects of the low molecular weight fucoidan on the bone osteogenic differentiation properties (Q42405752) (← links)
• Rubus coreanus Miq. extract promotes osteoblast differentiation and inhibits bone-resorbing mediators in MC3T3-E1 cells (Q42798300) (← links)
• Soybean ethanol extract increases the function of osteoblastic MC3T3-E1 cells (Q42829585) (← links)
• Influence of ferutinin on bone metabolism in ovariectomized rats. II: role in recovering osteoporosis. (Q43057016) (← links)
• Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice (Q44509153) (← links)
• Antiosteoporotic effect of ethanol extract of Cissus quadrangularis Linn. on ovariectomized rat (Q44651637) (← links)
• Evidence of Estrogenic Effect by the Three-Month-Intervention of Isoflavone on Vaginal Maturation and Bone Metabolism in Early Postmenopausal Women (Q44653498) (← links)
• Ketogenic Diet Compromises Both Cancellous and Cortical Bone Mass in Mice (Q47751802) (← links)
• Effect of aqueous extract of Solanum xanthocarpum Schrad. & Wendl. on postmenopausal syndrome in ovariectomized rats (Q48196741) (← links)
• Effects of different doses of ferutinin on bone formation/resorption in ovariectomized rats. (Q51323148) (← links)
• Sialoglycoproteins prepared from the eggs of Carassius auratus prevent bone loss by inhibiting the NF-κB pathway in ovariectomized rats. (Q51562477) (← links)
• Anti-osteoporotic activity of puerarin 6"-O-xyloside on ovariectomized mice and its potential mechanism. (Q52952695) (← links)
• Estrogen after ischemic stroke: clinical basis and design of the Women's Estrogen for Stroke Trial. (Q53028018) (← links)
• A combination of soy isoflavones and cello-oligosaccharides changes equol/O-desmethylangolensin production ratio and attenuates bone fragility in ovariectomized mice. (Q53098905) (← links)
• Rosmarinic acid exerts an antiosteoporotic effect in the RANKL-induced mouse model of bone loss by promotion of osteoblastic differentiation and inhibition of osteoclastic differentiation. (Q54310881) (← links)
• Intranasal administration of estradiol in combination with progesterone to oophorectomized women: a pilot study (Q67749359) (← links)
• Ovarian status influences the skeletal effects of tamoxifen in adult rats (Q71810652) (← links)
• Differential effects of estrogen treatment on bone mineral density of the spine, hip, wrist and total body in late postmenopausal women (Q72010337) (← links)
• Hip fracture (Q72532425) (← links)
• Effect of long‐term hormone replacement therapy on the bone in ovariectomized women with cancer (Q74449449) (← links)
• Selective estrogen receptor modulators: a new category of therapeutic agents for extending the health of postmenopausal women (Q77690812) (← links)
• Soy isoflavones' osteoprotective role in postmenopausal women: mechanism of action (Q77763312) (← links)
• Effect of Gengnianchun Recipe on bone mineral density, bone biomechanical parameters and serum lipid level in ovariectomized rats (Q79791391) (← links)
• A polysaccharide from the dried rhizome of Drynaria fortunei (Kunze) J. Sm. prevents ovariectomized (OVX)-induced osteoporosis in rats (Q89742737) (← links)
• Imperatorin promotes osteogenesis and suppresses osteoclast by activating AKT/GSK3 β/β-catenin pathways (Q92292569) (← links)
• Circaea mollis Siebold & Zucc. Alleviates postmenopausal osteoporosis in a mouse model via the BMP-2/4/Runx2 pathway (Q93160130) (← links)